ReviewDigestive diseases and sciences2021
An Update on the Management of Budd-Chiari Syndrome.
Review in Digestive diseases and sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 72 citations in OpenAlex.
- Accessory hepatic vein recanalization for Budd-Chiari syndrome: a systematic review and meta-analysis.BMC gastroenterology · 2023Pooled it
- Effect of Direct Oral Anticoagulants Versus Traditional Anticoagulation in Budd-Chiari Syndrome.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/HemostasisPooled it
- Successful anesthetic management of >10-liter blood loss in a Budd-Chiari syndrome patient undergoing living donor liver transplantation: A case report and review of literature.Pakistan journal of medical sciences · 2026Article
- Ultrasound Characteristics of Budd-Chiari Syndrome: A Multicenter Analysis.Digestive diseases (Basel, Switzerland) · 2026Article
- Elevated P-RBC complexes are associated with thrombotic risk and diagnostic potential in myeloproliferative neoplasms: a retrospective cohort study.American journal of translational research · 2026Article
- Unusual Etiology of Budd-Chiari Syndrome in an Adolescent: A Case of Combined Thrombophilic Disorder.Clinical case reports · 2025Article
- Analysis of risk factors for recurrence of Budd-Chiari syndrome: A retrospective study with zero-inflated model.Medicine · 2025Observational
- Review
- Navigating the crossroads: exploring the intersection of celiac disease and Budd-Chiari syndrome - insights, challenges, and management strategies.Annals of medicine and surgery (2012) · 2025Review
- A Rare Case of Budd-Chiari Syndrome in a Young Female.Clinical case reports · 2025Article
- Interventions in Budd-Chiari syndrome: an updated review.Abdominal radiology (New York) · 2025Review
- Article
- Intravenous leiomyomatosis presenting as Budd-Chiari syndrome: a case report and literature review.Orphanet journal of rare diseases · 2025Review
- Behçet's disease and factor V Leiden: A thrombogenic synergy causing budd-chiari syndrome.Radiology case reports · 2025Article
- Common features of Budd Chiari syndrome in Sudanese population: a computed tomography-based review and descriptive analysis.Frontiers in medicine · 2025Article
- Case Report: Budd-Chiari-like syndrome in a cat with polycystic kidney and liver disease.Frontiers in veterinary science · 2025Article
- Neoplastic Pseudocirrhosis Pathophysiological Deepening.Digestive diseases and sciences · 2024Article
- Acute Onset Budd-Chiari Syndrome in the Postpartum Period: A Case of Missed Diagnosis Leading to Rapid Deterioration.Cureus · 2024Article
- Splenectomy unveils thrombocytosis in underlying myeloproliferative neoplasms with extrahepatic portal vein obstruction.Intractable & rare diseases research · 2024Article
- Point-of-care ultrasound in the diagnosis and treatment of Budd-Chiari syndrome: A rare case report and literature review.Heliyon · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Budd-Chiari syndrome (BCS) is an uncommon condition, caused by obstruction to hepatic venous outflow. It is largely underdiagnosed, and a high index of suspicion is required for any patient with unexplained portal hypertension. The understanding of its etiology and pathology is improving with advances in diagnostic techniques. Recent studies reported an identifiable etiology in > 80% of cases. Myeloproliferative neoplasm (MPN) is the most common etiology, and genetic studies help in diagnosing latent MPN. Better cross-sectional imaging helps delineate the site of obstruction accurately. The majority of BCS patients are now treated by endovascular intervention and anticoagulation which have improved survival in this disease. Angioplasty of hepatic veins/inferior vena cava remains under-utilized at present. While surgical porto-systemic shunts are no longer done for BCS, liver transplantation is reserved for select indications. Some of the unresolved issues in the current management of BCS are also discussed in this review.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.